Literature DB >> 23663917

Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year.

Judith Stephenson1, Jill Shawe, Sabeena Panicker, Nataliya Brima, Andrew Copas, Ulrike Sauer, Chris Wilkinson, Hannat Akintomide, Paul O'Brien.   

Abstract

BACKGROUND: There is growing interest from women and clinicians in extended or tailored use of the combined oral contraceptive (COC) pill. Potential advantages include less bleeding, greater contraceptive efficacy and user satisfaction. We examined the effect of a tailored pill regimen, compared with the standard regimen, on continuation and satisfaction rates at 1 year and associated bleeding patterns. STUDY
DESIGN: This was a randomized controlled trial with 503 women aged 18-45 years. Women were randomized to either the standard regimen (21 daily pills followed by a 7-day pill-free interval) or tailored regimen (daily pills until three consecutive days bleeding triggers a 3-day pill-free interval) of Microgynon 30® (ethinyl oestradiol 30 mcg, levonorgestrel 150 mcg). Primary outcome was COC continuation at 12 months; secondary outcomes included satisfaction with pill regimen regarding contraception and bleeding pattern. Daily electronic diaries were used to record women's pill use, switching to other contraceptive methods, menstrual bleeding patterns and satisfaction levels.
RESULTS: Eighty-three percent of women were already taking the COC at recruitment, 13% were restarting the COC and 4% were first time COC users. Seventy-one percent of all women were followed up at 12 months. Continuation rates at 1 year were 82% in the tailored arm versus 80% in the standard arm [odds ratio (OR)=1.13; 95% confidence interval (CI)=0.67-1.91]. Satisfaction with contraceptive regimen was 86% (tailored) versus 94% (standard) (OR=0.37; 95% CI=0.17-0.79), and satisfaction with bleeding pattern was 79% versus 87%, respectively (OR=0.53; 95% CI=0.30-0.93). Median number of bleeding days per month was 2.4 (tailored) and 4.9 (standard). Incidence, duration and intensity of bleeding episodes were significantly lower in the tailored arm.
CONCLUSIONS: In women familiar with standard use of the COC, switching to tailored COC use or continuing with standard use were both associated with high COC continuation rates and high satisfaction with contraceptive regimen and bleeding pattern. While significant differences tended to favor the standard group, tailored COC use was associated with significantly less bleeding, suited some women very well and can provide a suitable alternative to standard use.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Combined oral contraceptive pill; Randomized control trial; Standard use; Tailored use

Mesh:

Substances:

Year:  2013        PMID: 23663917     DOI: 10.1016/j.contraception.2013.03.014

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

Review 1.  Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception.

Authors:  Alison Edelman; Elizabeth Micks; Maria F Gallo; Jeffrey T Jensen; David A Grimes
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29

Review 2.  There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.

Authors:  Chelsea B Polis; Rubina Hussain; Amanda Berry
Journal:  Reprod Health       Date:  2018-06-26       Impact factor: 3.223

Review 3.  Hormonal and intrauterine methods for contraception for women aged 25 years and younger.

Authors:  Jamie Krashin; Jennifer H Tang; Sheila Mody; Laureen M Lopez
Journal:  Cochrane Database Syst Rev       Date:  2015-08-17

4.  Offering extended use of the combined contraceptive pill: a survey of specialist family planning services.

Authors:  Ulrike Sauer; Sue Mann; Nataliya Brima; Judith Stephenson
Journal:  Int J Womens Health       Date:  2013-09-30

Review 5.  Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.

Authors:  Rossella E Nappi; Andrew M Kaunitz; Johannes Bitzer
Journal:  Eur J Contracept Reprod Health Care       Date:  2015-11-17       Impact factor: 1.848

Review 6.  Use of Combined Oral Contraceptives in Perimenopausal Women.

Authors:  Moon Kyoung Cho
Journal:  Chonnam Med J       Date:  2018-09-27

7.  Women's sexual experiences as a side effect of contraception in low- and middle-income countries: evidence from a systematic scoping review.

Authors:  Shannon N Wood; Celia Karp; Linnea Zimmerman
Journal:  Sex Reprod Health Matters       Date:  2020-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.